Literature DB >> 25748036

LncRNAs and neoplasia.

Mustafa Isin1, Nejat Dalay2.   

Abstract

Long noncoding RNAs are emerging as new mediators of tumorigenesis by virtue of their various functions and their capacity to induce different mechanisms as a result of their wide spectrum of interactions. They play critical roles in a broad range of cellular processes including regulation of gene expression, imprinting, chromatin modification, transcription and posttranslational processing. Expression and activity of lncRNAs are deregulated in several types of human cancer. Impairment of lncRNA activity may affect key components of the cellular gene regulatory networks and is associated with deregulation of a large number of cellular oncogenic pathways. LncRNAs are also being evaluated as diagnostic and prognostic biomarkers and may provide targets for potential therapeutic applications. An improved understanding of the roles played by lncRNAs in cancer will lead to more effective therapeutic strategies. In this review we summarize the current knowledge on lncRNAs and their function as mediators of tumor development.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cancer; LncRNA; Non-coding RNA

Mesh:

Substances:

Year:  2015        PMID: 25748036     DOI: 10.1016/j.cca.2015.02.046

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  41 in total

1.  Long non-coding RNA BRAF-regulated lncRNA 1 promotes lymph node invasion, metastasis and proliferation, and predicts poor prognosis in breast cancer.

Authors:  Jing Jiang; Sheng-Hong Shi; Xu-Jun Li; Long Sun; Qi-Dong Ge; Chao Li; Wei Zhang
Journal:  Oncol Lett       Date:  2018-04-17       Impact factor: 2.967

2.  Long-noncoding RNAs in basal cell carcinoma.

Authors:  Michael Sand; Falk G Bechara; Daniel Sand; Thilo Gambichler; Stephan A Hahn; Michael Bromba; Eggert Stockfleth; Schapoor Hessam
Journal:  Tumour Biol       Date:  2016-02-09

3.  Transcription factor Oct4 promotes osteosarcoma by regulating lncRNA AK055347.

Authors:  Hongwu Fan; Guangyao Liu; Changfu Zhao; Xuefeng Li; Xiaoyu Yang
Journal:  Oncol Lett       Date:  2016-11-21       Impact factor: 2.967

Review 4.  The crucial roles of long noncoding RNA SNHGs in lung cancer.

Authors:  Feng Chen; Fa Zhang; Yu-Fang Leng; Ya-Jing Shi; Jian-Ming Zhang; Yong-Qiang Liu
Journal:  Clin Transl Oncol       Date:  2022-08-25       Impact factor: 3.340

5.  LncRNA PITPNA-AS1/miR-223-3p/PTN axis regulates malignant progression and stemness in lung squamous cell carcinoma.

Authors:  Bi-Hao Peng; Yu-Fei Ji; Xiao-Jian Qiu
Journal:  J Clin Lab Anal       Date:  2022-05-19       Impact factor: 3.124

Review 6.  Long noncoding RNAs in hepatocellular carcinoma: Novel insights into their mechanism.

Authors:  Yong-Ru Liu; Rui-Xue Tang; Wen-Ting Huang; Fang-Hui Ren; Rong-Quan He; Li-Hua Yang; Dian-Zhong Luo; Yi-Wu Dang; Gang Chen
Journal:  World J Hepatol       Date:  2015-12-08

7.  LncRNA-ENST00000556926 regulates the proliferation, apoptosis and mRNA transcriptome of malignant-transformed BEAS-2B cells induced by coal tar pitch.

Authors:  Yonghang Zhu; Zhongqiu Li; Weiguang Wang; Linhao Jing; Qi Yu; Zhenkai Li; Xu Chen; Jiatong Zhang; Peng Zhang; Feifei Feng; Qiao Zhang
Journal:  Toxicol Res (Camb)       Date:  2021-11-06       Impact factor: 3.524

8.  LncRNA RBM5-AS1 Promotes Osteosarcoma Cell Proliferation, Migration, and Invasion.

Authors:  Biyong Deng; Runsang Pan; Xin Ou; Taizhe Wang; Weiguo Wang; Yingjie Nie; Houping Chen
Journal:  Biomed Res Int       Date:  2021-03-15       Impact factor: 3.411

9.  BALR-6 regulates cell growth and cell survival in B-lymphoblastic leukemia.

Authors:  Norma I Rodríguez-Malavé; Thilini R Fernando; Parth C Patel; Jorge R Contreras; Jayanth Kumar Palanichamy; Tiffany M Tran; Jaime Anguiano; Michael J Davoren; Michael O Alberti; Kimanh T Pioli; Salemiz Sandoval; Gay M Crooks; Dinesh S Rao
Journal:  Mol Cancer       Date:  2015-12-22       Impact factor: 27.401

10.  Long non-coding RNA PCAT6 regulates bladder cancer progression via the microRNA-143-3p/PDIA6 axis.

Authors:  Yuanjie Zhang; Lin Chen; Gang Luo
Journal:  Exp Ther Med       Date:  2021-07-01       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.